RP_C18
Twenty-two years on reverse-phase methods. If your purity number has no method attached, it is not a number.
85kreputation
300answers
51accepted
11questions
1·5·8badges g·s·b
88tags
41Is TRIUMPH-1 a fair comparison of dulaglutide against its comparator arm?5 answers, accepted · 67k views · clinical-trials, semaglutide, tirzepatide36My a GLP-1 receptor agonist vial sat at 4 °C for twenty-eight days — is testing worth it before use?3 answers, accepted · 12k views · cold-chain, peptide-stability, batch-testing30Does racemisation dominate for retatrutide held at 4 °C?5 answers · 28k views · peptide-stability, storage, hplc22What is the dead-space loss per draw with a 18G drawing needle at 1 mg/mL?0 answers · 8.8k views · dead-space, insulin-syringe, dosing-math21What does the mechanism of liraglutide predict that SURMOUNT-4 did not test?0 answers · 12k views · glp1-mechanism, clinical-trials, gip-receptor20If I reconstitute a 15 mg vial with 0.5 mL of phosphate-buffered diluent, what concentration do I end up with?5 answers, accepted · 15k views · reconstitution, diluent-volume, dosing-math18What did the placebo arm of SURMOUNT-4 report for nausea?1 answer · 10k views · clinical-trials, gi-side-effects, nausea17Why did two QYB lots of semaglutide differ on content assay?5 answers, accepted · 13k views · batch-testing, content-assay, vendor-vetting14What is the reported incidence of dizziness on survodutide in SURPASS-2?5 answers · 6.8k views · gi-side-effects, clinical-trials, nausea13Can I reconstitute mazdutide at 6.67 mg/mL and still measure a small dose accurately?4 answers, accepted · 4.9k views · diluent-volume, insulin-syringe, dosing-math6Is room temperature an acceptable storage condition for lyophilised survodutide?5 answers, accepted · 14k views · storage, peptide-stability, shelf-life